Company profilePharmaceutical#124 of 1,318 in Pakistan✓ No DRAP alerts

NAWAN LABORATORIES (PVT) LTD.

Pharmaceutical company · 136 brands · 135 molecules

Ranked #101 of 207 companies in Quinolone Antibacterials

136 registered products 47 pharmaceutical brands 135 distinct molecules 0 DRAP alerts

Company overview

136
registered products
47
pharmaceutical brands
135
distinct molecules
5
therapeutic classes
0
DRAP alerts

NAWAN LABORATORIES (PVT) LTD. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 136 product registrations across 135 distinct molecules. It is the 124th largest registrant in Pakistan by product count, and ranks 101st of 207 in Quinolone Antibacterials. Its portfolio is concentrated in Quinolone Antibacterials and Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord). It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by NAWAN

77 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) 2

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

77
ceilings with an approval date
0
not revised in 2+ years
2025
oldest approval year
202577

Top molecules by brand count

Ceftriaxone7 brands
Escitalopram4 brands
Azithromycin4 brands
Linezolid4 brands
Cefixime4 brands
Fexofenadine4 brands
Atorvastatin4 brands
Paroxetine3 brands
Rivaroxaban3 brands

Therapeutic classes

Quinolone Antibacterials · 2Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) · 2Antiemetics & Antinauseants · 1Drugs For Obstructive Airway Diseases, Systemic · 1Other Beta-Lactam, Cephalosporins & Penems · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official153 products · Rs 46.32 – Rs 13,206.43
Median across source: Rs 409

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

BIO LABS (PVT) LTD. holds 112 molecules not in this portfolio
000 I.UAmlodipineAprepitantAremetherArtesunateAscorbic Acid
NEUTRO PHARMA (PVT) LTD. holds 103 molecules not in this portfolio
AcetylcysteineAcyclovirAlbendazoleAmikacinAnastrazoleAnastrozole
HIGH - Q INTERNATIONAL holds 111 molecules not in this portfolio
000 I.UAcetyl L-CarnitineAmikacinAmlodipineAnastrozoleAprepitant

Get the full profile for NAWAN

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.